| RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry PA Juge, JA Sparks, S Gazal, E Ebstein, R Borie, MP Debray, ... Rheumatology Advances in Practice, rkae059, 2024 | | 2024 |
| OP0202 DECIPHERING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE PHENOTYPES USING UNSUPERVISED HIERARCHICAL CLUSTERING ANALYSIS: RESULTS FROM A LARGE COLLABORATIVE … PA Juge, B Granger, L El Houari, G Mcdermott, T Doyle, C Kelly, G Koduri, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 78-79, 2024 | | 2024 |
| High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study SR Desai, N Sivarasan, KA Johannson, PM George, DA Culver, ... The Lancet Respiratory Medicine 12 (5), 409-418, 2024 | 8 | 2024 |
| Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study M Kallieri, AI Papaioannou, E Zervas, E Fouka, K Porpodis, MH Mitrova, ... Clinical and experimental allergy: journal of the British Society for …, 2024 | | 2024 |
| Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study NK Gatselis, A Lyberopoulou, V Lygoura, G Giannoulis, A Samakidou, ... European Journal of Internal Medicine 122, 78-85, 2024 | 2 | 2024 |
| Multiple Behavioral Risk Factors As Assets for Chronic Disease Prevention: Observations From Urban Primary Care Settings in Crete, Greece EK Symvoulakis, P Stachteas, E Smyrnakis, P Volkos, AE Mantadaki, ... Cureus 16 (3), 2024 | | 2024 |
| Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease AM Matthaiou, N Bizymi, K Pagonidis, E Manousaki, M Fragkoulakis, ... Journal of Personalized Medicine 14 (2), 161, 2024 | | 2024 |
| A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema AU Wells, J Jacob, N Sverzellati, G Cross, J Barnett, A De Lauretis, ... Respiratory Research 25 (1), 33, 2024 | 2 | 2024 |
| Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality GA Margaritopoulos, A Proklou, A Trachalaki, DB Bonet, M Kokosi, ... ERJ Open Research 10 (1), 2024 | 1 | 2024 |
| Hypersensitivity Pneumonitis: Challenges of a Complex Disease D Calaras, A David, E Vasarmidi, K Antoniou, A Corlateanu Canadian Respiratory Journal 2024 (1), 4919951, 2024 | | 2024 |
| Déchiffrer la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde en utilisant une analyse en cluster hiérarchique non supervisée: résultats d’une … PA Juge, B Granger, L El Houari, G Mcdermott, T Doyle, C Kelly, K Gouri, ... Revue du Rhumatisme 90, A27-A28, 2023 | | 2023 |
| Corrigendum: Post-COVID-interstitial lung disease: Insights from a machine learning radiographic model A Tzouvelekis, T Karampitsakos, V Sotiropoulou, M Katsaras, P Tsiri, ... Immune-Mediated Lung Injury, 89, 2023 | | 2023 |
| Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial M Molina-Molina, JG Shull, V Vicens-Zygmunt, P Rivera-Ortega, ... European Respiratory Journal 62 (4), 2023 | 3 | 2023 |
| SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis I Barbayianni, P Kanellopoulou, D Fanidis, D Nastos, ED Ntouskou, ... Nature Communications 14 (1), 5882, 2023 | 6 | 2023 |
| Fibrinogen and fractional exhaled nitric oxide as potential markers of lung functional impairment in clinically stable non-cystic fibrosis bronchiectasis N Bizymi, AM Matthaiou, G Pitsidianakis, KM Antoniou, N Tzanakis European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Role of virtual multidisciplinary team meetings in the post-COVID era: a global survey to evaluate the ILD diagnostic pathway G Lough, R Abdulqawi, G Amanda, K Antoniou, A Azuma, A Bayoumy, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Nintedanib for patients with CTD related pulmonary fibrosis: real-life data. E Vasarmidi, PA Juge, E Bibaki, N Tzanakis, R Borie, P Dieude, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| The involvement of myeloid-derived suppressor cells in the pathogenesis and lung functional impairment in bronchiectasis AM Matthaiou, N Bizymi, G Pitsidianakis, N Tzanakis, KM Antoniou European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Screening for ILD in RA: a survey of 1132 patients with RA AM Hoffmann-Vold, K Antoniou, J Avouac, E Bendstrup, G Brown, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Follow-up of patients with severe eosinophilic asthma receiving benralizumab for one year (gReek rEAl Life regIStry of benralizuMab: REALISM Study) C Kontogianni, K Samitas, P Bakakos, N Rovina, S Loukides, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
